"SEER Program" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)
- SEER Program
- Program, SEER
- SEER Program (National Cancer Institute (U.S.))
- Surveillance, Epidemiology, and End Results Program
Below are MeSH descriptors whose meaning is more general than "SEER Program".
Below are MeSH descriptors whose meaning is more specific than "SEER Program".
This graph shows the total number of publications written about "SEER Program" by people in this website by year, and whether "SEER Program" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "SEER Program" by people in Profiles.
Osazuwa-Peters N, Barnes JM, Okafor SI, Taylor DB, Hussaini AS, Adjei Boakye E, Simpson MC, Graboyes EM, Lee WT. Incidence and Risk of Suicide Among Patients With Head and Neck Cancer in Rural, Urban, and Metropolitan Areas. JAMA Otolaryngol Head Neck Surg. 2021 12 01; 147(12):1045-1052.
Li M, Cai B, Mauldin P, Lu ZK. Medical costs and associated racial/ethnic and sex disparities in erythropoiesis-stimulating agent use: anemia management under the Medicare reimbursement policy. J Manag Care Spec Pharm. 2021 Aug; 27(8):1142-1152.
Mehta NK, Nguyen SA, Chang BA, Nathan CA. Trend Analysis of Cutaneous Squamous Cell Carcinoma of the External Lip From 1975 to 2016. JAMA Otolaryngol Head Neck Surg. 2021 07 01; 147(7):624-631.
Sharma RK, Irace AL, Schlosser RJ, Overdevest JB, Rowan NR, Troob SH, Gudis DA. Conditional and Overall Disease-Specific Survival in Patients With Paranasal Sinus and Nasal Cavity Cancer: Improved Outcomes in the Endoscopic Era. Am J Rhinol Allergy. 2022 Jan; 36(1):57-64.
Zahnd WE, Gomez SL, Steck SE, Brown MJ, Ganai S, Zhang J, Arp Adams S, Berger FG, Eberth JM. Rural-urban and racial/ethnic trends and disparities in early-onset and average-onset colorectal cancer. Cancer. 2021 01 15; 127(2):239-248.
Zheng YJ, Ho C, Lazar A, Ortiz-Urda S. Poor melanoma outcomes and survival in Asian American and Pacific Islander patients. J Am Acad Dermatol. 2021 Jun; 84(6):1725-1727.
Skochdopole AJ, Kutlu OC, Engelhardt KE, Lancaster WP, Abbott AM, Camp ER. High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas. J Surg Res. 2020 12; 256:198-205.
Jeon CY, Lin YC, Klempner SJ, Wu BU, Kim S, Waters KM, Haile RW. Endoscopic History and Provider Characteristics Influence Gastric Cancer Survival in Asian Americans. Cancer Prev Res (Phila). 2020 09; 13(9):773-782.
Traven SA, Brinton DL, Walton ZJ, Leddy LR. A propensity-score matched analysis of limb salvage vs amputation for osteosarcoma. J Surg Oncol. 2019 Dec; 120(7):1252-1258.
Janz TA, Camilon PR, Cheung AY, Nguyen SA, Meyer TA, McRackan TR, Lambert PR. Characteristics and Outcomes of Pediatric Vestibular Schwannomas. Otol Neurotol. 2019 09; 40(8):1047-1053.